Mirum Pharmaceuticals
MIRM
96.13
+0.62
+0.65%
Mirum Pharmaceuticals
US · MIRM
#2051 by market cap
Listed 2019
96.13
+0.62
+0.65%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
About Mirum Pharmaceuticals
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products pipeline includes Maralixibat, Cholbam, Ctexli, Volixibat, Brelovitug, MRM-3379, and Zilurgisertib. The company was founded by Niall O'Donnel, Michael G. Grey, and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.
- Founded
- 2018
- CEO
- Mr. Christopher Peetz
- Employees
- 372
- Headquarters
- Foster City, California, United States of America
- Fiscal year end
- 12-31
- Website
- mirumpharma.com
Company profile
- Exchange
- US
- Symbol
- MIRM
- Market-cap rank
- #2051
- Listing date
- 2019-07-18
- Market cap
- 6.28B
- Float cap
- 5.45B
- Shares out
- 65.28M
- Float shares
- 56.74M
Sectors & themes
Biotechnology
Fractional Shares JP
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Mirum Pharmaceuticals discussion 0 comments